Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone in patients with platinum-resistant...
Paul Edwards, Chief People Officer, Ardena Headshot of Paul Edwards, Chief People Officer of Ardena, pictured against a backdrop featuring...
Allowed claims cover real-time dental speech capture, schema-driven structured SOAP generation, PMS-native publishing, and automated care-gap and revenue opportunity checklists...
The cheapest breast augmentation in Florida is at Sarasota Surgical Arts SARASOTA, FLORIDA / ACCESS Newswire / March 2, 2026...
Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
FRISCO, Texas and TOLEDO, Ohio, March 1, 2026 /PRNewswire/ -- Public Storage (NYSE: PSA) and Welltower (NYSE: WELL) today announced a...
TOKYO, March 01, 2026 (GLOBE NEWSWIRE) -- OrganTech, Inc. announced that its research team has defined a minimal stem cell...
WriteUpp practice management platform combines automated SMS reminders and configurable booking rules to help healthcare providers recover lost revenue and...
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026...
Bezuclastinib mean TSS reduction deepens to –32.0 points at 48 weeks of treatment with further improvement shown across all measured...